Back

A non-biopsy genetic risk detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2018

About the speaker

Photo
Assistant Professor Mihai-Nelu Trofenciuc

Vasile Goldis Western University, Arad (Romania)

46 More presentations in this session

Presentation thumbnail
Professor H. Sabbah (Detroit, US)
Abstract Slides
Presentation thumbnail
Mr M. Lichy (Bratislava, SK)
Abstract
Presentation thumbnail
Doctor M. Gawor (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor M. Vanderheyden (Aalst, BE)
Abstract
Presentation thumbnail
Mr J. Berg (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Webinar
The essential skill in cardio-oncology: baseline cardiotoxicity risk stratification
8 March 2021
thumbnail
Congress Presentation
Induction of interferon-related genes limits the cardiotoxicity of liposomal doxorubicin in pigs
22 April 2018
thumbnail
Congress Presentation
3D strain echocardiography in detection of subclinical left ventricle dysfunction as a marker of early-onset anthracycline cardiotoxicity among children treated for acute lymphoblastic leukemia.
21 June 2025
thumbnail
Congress Presentation
Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources